ABNewswire - Press Release Distribution Service: June 2022

Thursday, June 30, 2022

Blood Cancer Drugs Market Recent Developments, Growth Opportunities Forecast Report 2022-2029 | DataM Intelligence

Blood Cancer Drugs Market | DataM Intelligence

Major key companies which are contributing to the growth of the Blood Cancer Drugs Market include Amgen Inc., AstraZeneca PLC, Bayer AG, Celgene Corporation, Eli Lilly. Bristol-Myers Squibb Company, Gilead Sciences, Inc., Takeda Pharmaceutical Company Limited, Daiichi Sankyo Company, Limited, UCB SA among others.

Blood Cancer Drugs Market Growth Rate Outlook:

Cancer begins in blood-forming tissue, such as the bone marrow or the immune system's cells. Examples of blood cancer are leukemia, lymphoma, and multiple myeloma. Also called hematologic cancer. The drugs such as bosulif (bosutinib), bosutinib., busulfan, and busulfex (busulfan) are used in blood cancer treatment.

According to the DataM market research report, the global blood cancer drugs market size was valued at USD billion in 2021, it is projected to reach USD billion by 2029, with growth at a CAGR of % over the forecast period 2022-2029.

Growing awareness among healthcare professionals and patients about the possibility of early diagnosis of cancer and an increase in government funding for research is expected to increase the market growth during the forecast period. Institutes like National Cancer Institute (NCI) receive funds from the U.S. congress to support cancer-related activities.

Market Drivers:

Formulations of novel regulatory approvals for new drugs for blood cancer are expected to drive the growth. For instance, In July 2021, Food and Drug Administration approved asparaginase erwinia chrysanthemi (recombinant)-rywn) (Rylaze, Jazz Pharmaceuticals, Inc.) as a component of a multi-agent chemotherapeutic regimen for the treatment of acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LBL).

Moreover, in June 2021, Food and Drug Administration approved avapritinib (Ayvakit, Blueprint Medicines Corp.) for adult patients with advanced systemic mastocytosis (AdvSM), including patients with aggressive systemic mastocytosis (ASM), systemic mastocytosis with an associated hematological neoplasm (SM-AHN), and mast cell leukemia (MCL).

Market Restraints:

Drug approval is a lengthy process of research and regulatory approvals, which can be costly. Almost four phases of clinical trials and various stages of screening with regulatory bodies such as the FDA are involved in the drug approval process.

The costs of failed clinical trials are also high as the clinical trial phases involve huge investments. According to the Tufts Centre for the Study of Drug Development, the cost of bringing a new drug from its conception to shelves is about $2.7 billion. This cost has raised more than 10 folds, with the cost of bringing a new drug to the market being $320 million in the 1990s. Thus, indicating that the high drug approval costs hinder the growth of the blood cancer drugs market.

Market Opportunities:

Most of the companies in the blood cancer drugs market are vigorously investing in technologies such as artificial intelligence (AI) to save time and reduce R&D costs. Artificial intelligence (AI) is the simulation of human intelligence processes by machines, particularly computer systems, with the potential to outperform human intelligence. When compared to human analysis, this technology aids in the study of large quantities of chemical and biological data in order to uncover prospective drug candidates with higher success rates and at a faster speed. By matching blood cancer patients with the most relevant clinical trials, the technology also helps to speed up the patient recruiting process, lowering clinical trial expenditures. For instance, Johnson & Johnson has partnered with BenevolentAI, a UK-based artificial intelligence start-up, to mine data for the development of new oncology drugs.

COVID-19 Impact Analysis:

Due to the coronavirus pandemic many pharmaceutical industries have suspended the clinical trials. In a study, it is estimated that approximately 12,000 clinical trials are going on in the area of cancer. If these trails are stopped or suspended for any reason, it will have a profound impact on the industry. Beyond this, loss of the potential health benefits for patients already enrolled in the trials, the cost of an oncology phase 3 clinical trial is on average at least USD 20 million, which will impose a huge financial hurdle on companies for gaining approval for trial and identification for the patients for the second time. According to, the Centre for Drug Development (UK), the pandemic initially drew recruitment for UK clinical trials to an almost complete pause. From about April 2020 until July or August 2020, all British hospitals stopped recruiting patients into new clinical trials, and they even stopped treating some patients already in clinical trials, if the visits weren't deemed completely necessary – so clinical development definitely had to pause in the year 2020.

Download Sample Brochure @ https://www.datamintelligence.com/download-sample/blood-cancer-drugs-market

Recent Developments in the Industry:

In May 2021, Natco Pharma has received approval from the US health regulator for generic Lenalidomide capsules indicated for the treatment of adults with multiple myeloma, mantle cell lymphoma, and myelodysplastic syndromes. For Lenalidomide capsules in 5 mg, 10 mg, 15 mg, and 25 mg strengths, the company has received final approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA)
On March 2, 2021, Amgen announced that data from a multicenter, randomized Phase 3 study evaluating the efficacy, safety, and tolerability of BLINCYTO (blinatumomab) compared with consolidation chemotherapy before allogeneic hematopoietic stem cell transplantation (alloHSCT) in pediatric patients with high-risk first-relapse B-cell precursor acute lymphoblastic leukemia (B-ALL) were published in The Journal of the American Medical Association (JAMA).

Market Segmentation:

As per the research analysis, the global blood cancer drugs market is segmented by type into Leukemia, Non-Hodgkin lymphoma, Hodgkin lymphoma, and Myeloma. By drugs type into rituaxan/mabthera (rituximab), gleevac/glivec (imatinib), revlimid (lenalidomide), velcade (bortezomib), tasigna (nilotinib), pomalyst (pomalidomide), vidaza (azacitidine), kyprolis (carfilzomib), adcetris (brentuximab vedotin), others. By route of administration the market is further segmented into oral, parenteral, and others. By end-user into hospitals, clinics, and ambulatory surgical centers.

On the basis of drug type, the rituaxan/mabthera (rituximab) drugs segment is estimated to grow at highest CAGR of % during the forecast period (2022-2029). Mabthera was the first therapeutic monoclonal antibody that targets the CD20 marker on their surface. These cells are central to lot of blood cancers, including common forms of lymphoma and leukemia. It attacks these cells both directly and together with the body’s immune system. Also, in the United States, Europe, and other countries, it is approved for the treatment of adults with the following blood cancers, previously untreated and relapsed/refractory follicular lymphoma, previously untreated diffuse large B-cell lymphoma, and previously untreated and relapsed/refractory chronic lymphocytic leukemia. This drug is also approved for the treatment of adults with auto-immune diseases, severe active rheumatoid arthritis, pemphigus Vulgaris and severe active granulomatosis with polyangiitis and microscopic polyangiitis (GPA/MPA).
Based on type, the non-hodgkin lymphoma segment accounted for the largest market share of around % in 2020 and is expected to grow at a CAGR of % during the forecast period (2022-2029). Non-Hodgkin lymphoma has occupied the second-largest market share. Non-Hodgkin lymphoma is cancer that starts in white blood cells called lymphocytes, which are part of the body’s immune system. The advances in the diagnosis and treatment of non-Hodgkin's lymphoma have helped improve the prognosis for people with this disease.

Geographical Classification:

The global blood cancer drugs market is segmented into major countries including North America, Europe, South America, Asia Pacific, the Middle East, and Africa.

North America blood cancer drugs Market:

Awareness of early diagnosis and treatment of cancers, availability of advanced treatment procedures and drugs, advanced healthcare facilities, and financial aid in the U.S. and Canada have contributed to a significant market in the region. There is a large number of drugs approved for the treatment of various kinds of blood cancers in the United States. The list includes both branded and generic drugs that are widely used in combinations.

These market players are also expanding their blood cancer drug business with both organic and inorganic growth strategies. In January 2019, Eli Lilly acquired Loxo Oncology, a U.S.-based manufacturer of target drugs for blood and other cancer treatments. Its proprietary BTK inhibitor Pirtobrutinib (LOXO-305) is under clinical research for blood cancers.

The Asia Pacific is the most lucrative market for blood cancer drugs globally. It is likely to witness a CAGR of % during the forecast period (2021-2028) owing to the rising awareness of chemotherapy and radiation therapy. These cancer treatment procedures use a wide range of therapeutics. China, Australia, India, and Japan are the leading markets for blood cancer drugs in the region owing to a high prevalence rate of leukemia and lymphoma.

Make an Inquire before purchasing the full report @ https://www.datamintelligence.com/enquiry/blood-cancer-drugs-market

Competitive Analysis:

The global blood cancer drug market is highly competitive with the presence of major players. In the collaborations for development, broader product portfolios, and regional expansion in emerging markets are key strategic undertakings of these companies to increase their market share. The market is expected to grow increasingly crowded with several product launches during the forecast period.

Major Companies:

Major key companies which are contributing to the growth of the market include Amgen Inc., AstraZeneca PLC, Bayer AG, Celgene Corporation, Eli Lilly. Bristol-Myers Squibb Company, Gilead Sciences, Inc., Takeda Pharmaceutical Company Limited, Daiichi Sankyo Company, Limited, UCB SA among others.

Additional Benefits Post Purchase:

1) Unlimited Analyst support for a period of 1 year.

2) Any query with regards to the scope offered will be addressed within 24- 48 hours.

3) An excel sheet with market numbers will be provided separately.

The Full Report has the below insights:

The report offers a comprehensive evaluation of the market in terms of Market Value (US$) and Y-o-Y Growth Rates (%). It does so via in-depth qualitative insights, historical data (2020-2021), and verifiable projections about market size during the forecast period (2022-2029).
Visualize the composition of the global blood cancer drugs market segmentation by type, drug type, route of administration, end-user, and country highlighting the key commercial assets and players.

By Type: Leukemia, Non-Hodgkin lymphoma, Hodgkin lymphoma, Myeloma
By Drugs Type: Rituaxan/Mabthera (Rituximab), Gleevac/Glivec (Imatinib), Revlimid (Lenalidomide), Velcade (Bortezomib), Tasigna (Nilotinib), Pomalyst (Pomalidomide), Vidaza (Azacitidine), Kyprolis (Carfilzomib), Adcetris (Brentuximab Vedotin), Others
By Route of Administration: Oral, Parenteral, Others
By End User: Hospitals, Clinics, Ambulatory Surgical Centers
By Country: North America, South America, Europe, Asia Pacific and the Middle East and Africa

Identify commercial opportunities in the global blood cancer drugs market by analyzing trends and co-development deals.
The report also covers data insights on various industry forces such as porter's five forces analysis, supply chain analysis, pricing analysis, regulatory analysis, reimbursement analysis, and unmet needs, etc.
Excel data sheet with thousands of data points of global blood cancer drugs market-level 4/5 segmentation.
PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
Product mapping in excel for the key product of all major market players
The report will provide access to approximately 69 market data tables, 68 figures, and close to 200 pages.

Media Contact
Company Name: DataM Intelligence
Contact Person: Sai
Email:Send Email
Phone: +1 877 441 4866
Country: United States
Website: https://www.datamintelligence.com/research-report/blood-cancer-drugs-market

Side View Camera System Market Size, Growth, and Analysis Report to 2029 | DataMIntelligence

DataM Intelligence

The Global Side View Camera System Market is expected to reach a CAGR of 111.6% during the forecast period (2022-2029).

Market Overview

Factors such expanded traveler vehicle and business vehicle creation, center around further developing eco-friendliness by embracing lightweight innovation, expanded utilization of electrical and electronic parts in vehicles are driving the side view camera framework market.

Download free sample @ https://www.datamintelligence.com/download-sample/side-view-camera-system-market

Market Dynamics

Show part is supposed to be the biggest market during the figure time frameThe presentation part is supposed to be the biggest market during the estimated time frame. The showcase section will hold the biggest market among any remaining parts because of the greater expense of presentations. The side camera framework requires 2 shows and the cost of such shows will continuously outperform the expense of different parts. Expanding speculations and improvements in regards to large-scale manufacturing of excellent Organic Light-Emitting Diode boards set out new plans and open doors for lighting and HMI makers.

For example, in August 2018, Denso Corporation, one of the central parts of the view camera framework market, put USD 270 million in JOLED Inc. JOLED was the primary organization to popularize printed OLED shows. With expanding, reception of cutting-edge show arrangements in the auto business would drive the interest for different presentation types in the side view camera frameworks market during the figure time frame.

Market Segmentation

By Camera Type

Single Camera System
Multi Camera System

By Component

Camera
ECU
Display

By Vehicle Type

Passenger Cars
Commercial Vehicle

By Distribution Channel

OEMs
Aftermarket

View full report @ https://www.datamintelligence.com/research-report/side-view-camera-system-market

Competitive Landscape

The global side view camera system market is consolidated due to the presence of major companies as the technology is still in the developing phase and requires a significant investment. Major companies include Continental AG, Valeo, BMW, Hyundai Mobis, Lexus Samvardhana Motherson, Robert Bosch, Magna International, Stoneridge and Denso Corporation. The major players in the market are known to incorporate numerous market strategies to achieve growth in the global side view camera system market; these include collaborations, acquisitions, product launches, contributions and mergers.

Trending Topics

Automotive Pumps Market

Automotive Steering System Market

Neuroendocrine Cancer Market Analysis on Segmentation, Regional and Country Level Forecast Report 2022-2029 | DataM Intelligence

Neuroendocrine Cancer Market | DataM Intelligence

Some of the key players which are contributing to the growth of the Neuroendocrine Cancer Market include Amgen, Inc, Bristol-Myers Squibb, Eli Lilly & Company, F. Hoffmann-La Roche Ltd., Ipsen Pharmaceuticals, Novartis AG, Pfizer Inc, Hutchinson Medipharma Limited, Tarveda Therapeutics, Progenics Pharmaceuticals, and others.

Neuroendocrine Cancer Market Overview:

The neuroendocrine tumor is a rare tumor that emerges from neuroendocrine cells, which are specialized body cells. It can arise everywhere in the body, although the pancreas, digestive tract, lungs, rectum, and appendix are the most common sites. It is possible for a neuroendocrine tumor to be benign or malignant.

Market Size Growth Rate:

According to the research report published by the DataM Intelligence, the global neuroendocrine cancer market size was valued at USD billion in 2021, it is projected to reach USD billion by 2029, with growth at a CAGR of % over the forecast period 2022-2029.

Increased incidences of neuroendocrine tumors (NETs) are predicted to boost demand for treatment options, boosting the market growth during the forecast period. Novel therapeutics and diagnostic products are being developed rapidly in this field. In addition, the neuroendocrine carcinoma therapy market is predicted to rise rapidly due to joint efforts and endeavors to identify medicines for difficult-to-treat disorders and the rising trend of studying next-generation sequencing techniques.

Market Drivers:

The rising prevalence of neuroendocrine carcinoma, technological improvements, more public awareness, and the expanding number of government initiatives drive market growth. Neuroendocrine tumors are becoming more common worldwide, despite being an uncommon disease. In the United States, more than 12,000 people are diagnosed with neuroendocrine tumors each year. As a result, the rising occurrence of neuroendocrine tumors aids in adopting medications for treating this rare disease.

Market Restraints:

The high cost of developing and treating neuroendocrine cancer is expected to hamper the market growth. A NET ( Neuroendocrine Tumor) treatment can be costly. For patients and their families, costs can cause stress and anxiety. Many people discover that, in addition to treatment expenditures, they have additional, unanticipated expenses associated with their care. Some patients cannot follow or complete their treatment plans due to the high cost of medical care. This may jeopardize their health and result in increased bills in the future.

Download Sample Brochure @ https://www.datamintelligence.com/download-sample/neuroendocrine-cancer-market

Market Opportunities

Drug trials are expected to increase market opportunities in the forecast period to increase research and development. For instance, increasing investments by government organizations is expected to drive market growth. For instance, organizations such as the Neuroendocrine Tumor Research Foundation (NETRF) have invested more than 1.5 USD million in developing advanced radiation therapy called Peptide Receptor Radionuclide Therapy (PRRT).

COVID-19 Impact Analysis

COVID-19 had a slow but steady negative influence on this market, as the pandemic has wreaked havoc on health services for other diseases like cancer, hypertension, diabetes management, and cardiovascular emergencies. The change in healthcare professionals' attention away from these diseases and toward the COVID-19 criticality has severely influenced the healthcare industry. COIVD-19 significantly impacted life sciences research, as it suspended research activities and slowed the advancement of most research and academic institutes, clinical research facilities, and other organizations. Many research institutes have been redirected to COVID-19 research to tackle the fast-progressing virus.

Recent Developments in the Industry:

On July 30^th, 2018, The US FDA approved Progenics Pharmaceuticals, Inc.'s New Drug Application for AZEDRA (iobenguane I 131) injection for treating patients with pheochromocytoma or paraganglioma who require systemic anticancer therapy.

Market Segmentation:

As per the research analysis, the neuroendocrine cancer market is segmented by therapy type into targeted therapy, somatostatin analogs (SSAs), and others. The market is further segmented by indication into small intestine, lungs, pancreas, gastrointestinal, and others. Based on route of administration the market is segmented into oral and parenteral and by end-user into hospitals, clinics and others.

On the basis of therapy, the somatostatin analogs ( SSAs) segment is estimated to grow at the highest CAGR of %during the forecast period (2022-2029). The therapy segment accounted for the largest market share of the global neuroendocrine cancer market in 2020. Somatostatin analogues are medications that prevent the body from producing excessive amounts of hormones. Some neuroendocrine tumors (NETs) produce high amounts of hormones, resulting in a disease known as carcinoid syndrome. People with carcinoid syndrome may benefit from somatostatin analogues. SSA's treatment procedure is considered to be safe. Patients resistant to surgery or radiation therapy are frequently treated with SSAs.

Make an Inquire before purchasing the full report @ https://www.datamintelligence.com/enquiry/neuroendocrine-cancer-market

Geographical Classification:

According to the report the market is divided into North America, South America, Europe, Asia-Pacific and Middle East.

North America Neuroendocrine Cancer Market:

North America is found to dominate the market as the United States and Canada have well-structured and developed healthcare systems. Owing to supporting insurance policies in the region, such as Medicare, Medicaid, and Tricare, that facilitate NET treatment. Other factors driving the market include modern healthcare facilities and substantial R&D investment by pharmaceutical companies and regional governments for cancer research.

Asia Pacific Neuroendocrine Cancer Market:

The Asia-Pacific neuroendocrine cancer market size was valued at USD billion in 2021, it is projected to reach at USD billion by 2029, with growth at a CAGR of % over the forecast period 2022-2029.

Competitive Analysis:

The major players are adopting several growth strategies such as acquisitions, product pipeline and collaborations, which are contributing to the growth of the neuroendocrine cancer market globally.

Major Companies:

Some of the key players which are contributing to the growth of the market include Amgen, Inc, Bristol-Myers Squibb, Eli Lilly & Company, F. Hoffmann-La Roche Ltd., Ipsen Pharmaceuticals, Novartis AG, Pfizer Inc, Hutchinson Medipharma Limited, Tarveda Therapeutics, Progenics Pharmaceuticals, and others.

Additional Benefits Post Purchase:

1) Unlimited Analyst support for a period of 1 year.

2) Any query with regards to the scope offered will be addressed within 24- 48 hours.

3) An excel sheet with market numbers will be provided separately.

The Full Report has the below insights

The report offers a comprehensive evaluation of the market in terms of Market Value (US$) and Y-o-Y Growth Rates (%). It does so via in-depth qualitative insights, historical data (2020-2021), and verifiable projections about market size during the forecast period (2022-2029).
Visualize the composition of the global neuroendocrine cancer market segmentation by therapy type, indication, route of administration, end-user and region highlighting the key commercial assets and players.

By Therapy Type: Targeted therapy, somatostatin analogs (SSAs) , and others.
By Indication: Small intestine, lungs, pancreas, gastrointestinal and others.
By Route of administration: Oral and parenteral.
By End-user: Hospitals, clinics and others.
By Region: North America, South America, Europe, Asia-Pacific and Middle East

Identify commercial opportunities in the global neuroendocrine cancer market by analyzing trends and co-development deals.
The report also covers data insights on various industry forces such as, porter’s five forces, regulations in each country, pipeline analysis and pricing analysis.
Excel data sheet with thousands of data points global neuroendocrine cancer market-level 4/5 segmentation.
PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
Product mapping in excel for the key product of all major market players
The report will provide access to approximately 50+ market data tables, 40+ figures, and close to 180 pages.

Pepsico (New York) and Kellogg Co (US) are the Key Players in the Savory Snack Products Market

MarketsandMarkets™

The global savory snack products market is estimated to be valued at USD 203.9 billion in 2022 and is projected to reach USD 263.0 billion by 2027 recording a CAGR of 5.2%

The savory snacks products market size is estimated to be valued at USD 203.9 billion in 2022 and is projected to reach USD 263.0 billion by 2027, recording a CAGR of 5.2% during the forecast period in terms of value. The demand for savory snack products is attributed by the significant change in the work culture which is promoting the demand for savory snacks among consumers.

Savory Snack Products Market

Key players in this market include PepsiCO (New York), Kellogg Co (US), General Mills Inc. (US), Calbee (Japan), ITC LIMITED (India), Mondelez International (US), Nestle SA (Switzerland), Grupo Bimbo (Mexico), Hain Celestial (US).

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=182914305

The existing players in the savory snacks products market are fixated upon improving their market shares, while the newer startups are being established rapidly in the savory snacks segment. Savory snacks products can be classified as a fragmented market as it has a large number of organized players at the global level as well as unorganized players present at the local level in several countries. There are numerous existing and emerging companies across the globe.

PepsiCo is an US based company was established in 1965 and is currently one of the leading players operating in the food and beverage specially in savory snack products market with a presence in nearly 200 countries with 22 brands. Some major brands include Lays, Cheetos, Ruffles, Frritos, Doritos, and Walkers. They currently manufacture snacks, such as potato chips, puffs, sticks, corn-based sticks, tortillas, nachos, and beef snacks. It focuses on launching new products in order to gain maximum market share. For instance, in January 2021, PepsiCo announced to launch new Doritos Flamin' hot cool ranch flavored tortilla chips. These new product launches are increasing the brand visibility of the company across the globe.

Kellogg is one of the leading companies in the breakfast cereals and ready-to-eat snacks industries. The company currently offers products in segments, such as crackers, cookies, savory snacks, toaster pastries, cereal bars, granola bars and bites, fruit-flavored snacks, and convenience foods, including ready-to-eat cereals, frozen waffles, veggie foods, and noodles. Special K, Cheeze-it, and Pringles are some of the popular brands of the company, which contribute majorly to its revenues. Kellogg Company is focusing in expanding their production facilities across the globe. For instance, in November 2019, Kellogg Company announced to expand its existing production facility located in Kunto, Poland. This new expansion is helping the company to increase the production capacity of Pringles, a renowned brand of chips across the globe.

Make an Inquiry @ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=182914305

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email:Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/savory-snack-products-market-182914305.html

Gelita AG and NITTA Gelatin, INC. are the major Key Players in the Collagen Market

MarketsandMarkets™

The global collagen market size is projected to reach USD 5.3 billion by 2026, recording a CAGR of 5.4%, in terms of value. Collagen has versatile properties that enable it to be extensively used in various industrial applications such as medical, cosmetics, and food & beverages

The global collagen market size is estimated to be valued at USD 4.1 billion in 2021 and is projected to reach USD 5.3 billion by 2026, recording a CAGR of 5.4% during the forecast period in terms of value. The demand for collagen is increasing moderately due to increasing health concerns and rising obesity among consumers.

Collagen Market

Key players in this market include GELITA AG (Germany), NITTA GELATIN, INC. (US), Weishardt Group (France), Darling Ingredients Inc. (US), Nippi Collagen NA Inc. (Japan), Vinh Hoan Corporation (Vietnam), Junca Gelatines S.L. (Spain), Lapi Gelatine S.p.a. (Italy), Gelnex (Brazil), Vital Proteins LLC. (US).

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=220005202

The key players are fixated upon improving their market shares, while their newer start-ups are being established rapidly in the market. The collagen market can be classified as a competitive market as it has the presence of a large number of organized players, accounting for a major part of the market share, present at the global level, as well as unorganized players present at the local level in several countries. There are numerous existing and emerging companies, particularly in the Asian markets.

GELITA AG is one of the leading manufacturers and suppliers of collagen proteins for various applications such as food, health & nutrition, pharmaceutical, specialties & fat, and protein & minerals. It manufactures three major products, namely, gelatin, collagen peptides, and collagen. It offers collagen and collagen peptides used in the production of meat products such as boiling sausage, cooked sausage, and low-fat pastries or ground meat. The company distributes high-quality tailor-made collagens for a wide range of products in food and nutritional supplement industries. The company has more than 18 production plants and sales offices, globally.

Nitta Gelatin, Inc. is a leading producer and supplier of high-quality gelatin, collagen peptides, and collagen proteins. The company is specialized in manufacturing collagen proteins sourced from bovine, porcine, and fish. They offer various types of collagen such as gelatin, native collagen and collagen peptides, which are used in applications such as food & beverage, health care, beauty & wellness, and technical. The company offers collagen peptides for cell cultures and coatings used in the pharmaceutical industry and collagen protein for protein-based food products.

Make an Inquiry @ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=220005202

About MarketsandMarkets™

Global Smart Grid Market Size to Grow $103.4 Billion by 2026

The global smart grid market is expected to grow from an estimated USD 43.1 billion in 2021 to USD 103.4 billion by 2026, at a CAGR of 19.1% during 2021-2026.

The global smart grid market is expected to grow from an estimated USD 43.1 billion in 2021 to USD 103.4 billion by 2026, at a CAGR of 19.1% during the forecast period. Modernization of aging grid infrastructure is one the primary factors driving market growth. Moreover, the government across the world is encouraging the investments in smart grids.

Smart grid technology enables the transition from a traditional energy distribution network to an intelligent electricity grid that allows two-way communication between the utility and its customers. The smart electric grid uses digital communication technologies, information systems, and automation for monitoring the energy flow and adjusting the changes in energy demand and supply. It also helps in real-time monitoring power consumption by coupling it with smart metering systems, providing consumers and suppliers with information on real-time power consumption. Thus, the smart grid helps improve system operating efficiency, thereby reducing the operational cost. Increasing demand for smart infrastructure in industrial, commercial, and residential environment to offers lucrative opportunities for the smart grid market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=208777577

The distribution segment is expected to dominate the smart grid market.

The distribution segment accounted for the largest share of the smart grid market, by application, in 2020. Efficient distribution application helps in quicker restoration of electricity after power disturbances, reduces operations and management costs for utilities, and ultimately lowers the power costs for consumers.

North America is expected to lead the smart grid market

North America includes countries such as the US, Canada, and Mexico. The US and Canada, which contribute heavily to the growth of the regional market. The region is estimated to account for the largest share of the global smart grid market, and a similar trend is expected to continue until 2026. One of the key reasons for the large market size is the early adoption of smart grid projects. The strong financial position of the US and Canada enables them to invest heavily in smart infrastructure platforms of the smart grid market.

The smart grid market in US is expected to grow mainly because it is the most mature market in terms of smart grid deployment, advanced IT infrastructure, the presence of several enterprises, and the availability of technical expertise in the country. Smart grid technology in the US is undergoing a considerable transformation as digital technologies are being applied to distributed energy resources. All these factors are expected to drive the growth of the market in North America.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=208777577

The key players in the Smart Grid Market include GE (US), ABB (Switzerland), Siemens (Germany), Schneider Electric (France), and Itron (US).

About MarketsandMarkets™:

Contact:

Mr. Aashish Mehra

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: 1-888-600-6441

Email: sales@marketsandmarkets.com

Content Source: https://www.marketsandmarkets.com/PressReleases/global-smart-grid.asp

Moonable Announces Public Launch with a Goal of Removing Financial Boundaries for Businesses

Moonable was created as a financial institute and an international banking system that makes it easier for its users to establish their business and make online transactions.

Moonable, a software development and fintech company with an aim of providing a sophisticated solution to businesses in making online transactions, is launching publically to finish the problem of global transactions being not enough interoperable with multiple instruments including crypto and very complex due to the involvement of multiple factors like currencies and country monetary policies. Moonable aims to help individuals establish their business internationally with ease.

A Solution to Fintech and Financial Services

Moonable has dedicated to building solutions for the Fintech and Financial Services ecosystems. Designed a mechanism for removing financial barriers between countries, societies, and businesses by establishing a gateway through multiple instruments designed for entrepreneurs, investors, and ex-pats.

Moonable has multiple services that make it unique and differentiate it from other fintech platforms.

Transfers & Batch Payments: Moonable has made it easier for people to make single and batch payments that are paying one or multiple recipients, instead of doing individual transactions. One can manually make a batch payment by adding employees and vendors one by one.
Multiple Account: Moonable allows its user to control all their business through a single click. Users can make multiple business accounts under a single private account. This allows them to switch their business rapidly, transfer money between them and help them save time. All the businesses can be linked by using a single email. Proper management of the business can help it grow and develop.
Cryptocurrency Conversion: Moonable allows to rapidly receive FIAT and convert it into cryptocurrencies allowing consumers and businesses to make transactions faster across multiple countries.
SaaS: Moonable has the goal to expand and enhance financial services across the world, unbanked societies and countries. While in LATAM and Africa fintech expansion is taking a lot of traction, these can benefit their communities by using our white label solution.
Tokenization: Moonable designed a framework that adapts to the tokenization industry, in these recent months NFTs have produced a significant effect on the way how assets can be sold transparently improving property ownership. By using our technology NFTs creators and businesses in the real state sector, and financial sector, among others can reduce up to 50% of their technology costs at the time of executing their projects.

Mission and Aims

The traditional banking system makes global transactions unnecessarily complex due to currency conversion and lengthy wait times. Cryptocurrencies have gained public and regulatory acceptance, yet financial institutions have been resistant to accept this new mode of finance. A platform like Moonable establishes a combined legal, software, and effective framework that aims to empower both public and private institutions. Its mission is to establish an international financial platform that makes international transactions of multiple currencies simple. They also aim to offer financial instruments that serve everyone in their community and help them establish their business.

Moonable – The Financial Platform for Digital Nomads

Moonable acts as a simplified platform that has access to EUR and GBP accounts. Every user can operate the account as an individual or as a business. The application provides the best rates across Europe. It also provides access to European IBAN, SEPA transfers, and international payments. The account is designed with security measures such as biometric authorization, multi-factor authentication, and tracking of all transactions made. At the end of each month, a consolidated bank statement is generated automatically. The statement is available in PDF, CSV, and XLS which makes it very accountant friendly. To help entrepreneurs provide a source of funds, an institutional letter can be generated from their account summarizing the accounts and since when is a customer of us. A full section to manage contacts is provided by Moonable. Even if the user has multiple accounts using multiple currencies the contact management has been made to easily add, edit and delete them.

Roadmap

Moonable has an insightful vision and aims to do even better in the future. According to their road map in the next 4 to 5 years they want to achieve a lot of milestones. They want to secure IBAN accounts of EUR and GBP, increase customer base in Spain and Baltic states, implement debit cards for individuals, focus on Italy, France, and Portugal, expand in the markets of the USA and Australia, create a Launchpad, and focus on LATAM & Africa open bank expansion.

Team

Marco Pirrongelli and Giordano Lugo are the founders and managing directors of Moonable along with other individuals. The team believed that technology would advance after the 2008 financial crisis since the world needed a healthy ecosystem. They created the tools to build the ecosystem using their Moonable project.

Further details about Moonable can be found on the project's official website and pitch deck.

About Moonable

Moonable is a software development company dedicated to enable the removal of financial boundaries between countries, societies and businesses by establishing a fully integrated bank solution designed for entrepreneurs, investors and ex-pats.

Website | Twitter | Instagram

Moonable

press@moonable.finance

https://www.moonable.finance/

Disclaimer:

The information provided in this release is not investment advice, financial advice or trading advice. It is recommended that you practice due diligence (including consultation with a professional financial advisor) before investing or trading securities and cryptocurrency.

Media Contact
Company Name: Moonable
Contact Person: Marco Pirrongelli
Email:Send Email
Phone: +3726991555
Address:J. Basanaviciaus g. 25
City: 03224 Vilnius
Country: Lithuania
Website: https://www.moonable.finance/

Toinrt International Exchange starts the Revolution of epoch-making Block chain

It is reported that in 2021, the total trading volume of the toinrt exchange exceeded 10 billion US dollars, the average daily trading volume of the platform was stable at around 900 million US dollars, and the total amount of social media attention exceeded 250000.

Toinrt (http://www.tionrt.cc) is an international digital diversified exchange located in New York, USA. Toinrt has served users all over the world. Toinrt's core team and investment consultant team are composed of experts from many countries around the world. The operation team has 20 years experience in blockchain industry. There are independent trading operations and operation centers in the United States, Canada, Singapore, Switzerland, Japan, Vietnam, Dubai, South Korea and Hong Kong.

Tionrt is full-featured and more user-friendly, and the exchange provides users with a rich product line. The exchange currently supports multi-currency trading with ultra-low fees, high-yielding wealth management products, deep liquidity contracts and high-speed contract trading markets, regular discounts on mainstream tokens, and a series of currency activities. In terms of security, tionrt gives full play to the technical advantages of the interaction between virtual currency and big data, ensures the safety and speed of transactions on the chain, and gives traders multiple scientific protection measures.

Compared with the traditional individual user service system, toinrt pays more attention to providing professional, convenient and secure digital products and services for institutions and professional users, aiming to improve the service system of the encryption market to a greater extent and meet the investment needs of all kinds of users. in the blockchain world, people are more and more pursuing rapid and efficient transaction settlement. Among them, high-speed contract trading has been highly recognized by the industry since it was launched as a rapid, efficient, simple and stable way of transaction settlement.

The rules of express contract trading are the most simple and straightforward. First, select the digital currency to be traded. The trading time interval is 1min, 3min, 5min and 60min. Within the risk range that we can control, we set the transaction amount, set the stop loss of earnings, and place orders according to the technical analysis of the currency direction trend. The characteristic of express contract trading is to close the position at maturity and settle on time. As a new driving project, the launch of extreme speed contract trading means that the platform provides a wide range of options for individuals and large capital institutions who want to enter the field of contract trading. In the future, tionrt will deepen the layout of NFT meta-universe Metaverse and gradually create a brand-new virtual digital civilization world.

As a rookie superstar project in the blockchain field, tionrt is committed to combining blockchain technology to create a digital intellectual property protection ecosystem. In the future, tionrt will focus on how to better improve business and community ecology, improve tionrt hard power, move forward to higher and farther blockchain landing applications, and start an epoch-making blockchain revolution!

Media Contact
Company Name: TIONRT LTD.
Contact Person: Media Relations
Email:Send Email
Address:244 MADISON AVENUE SUITE 1095
City: NEW YORK
Country: United States
Website: http://www.tionrt.cc

Patsco Windshield Repair Presents a New Way to Fix Windshields Without Drills or The Use of An Injector

A chipped windshield no longer has to ruin one's day as the auto glass repair brand releases its patented windshield repair kit

Windshield chips are as a result of considerable impact of an object on the windshield. These common and minute windshield chips or nicks are not usually synonymous with a complete overhaul, but with impact from the constant movements of the vehicle; contraction and expansion of the glass owing to changes in environmental temperature, gradual settling of dust in said chip, or even faulty installation practices, these negligible windshield chips can spiral to significant cracks requiring a reasonable amount of money to fix. It is thus imperative to fix these chips as soon as they are noticed.

Patsco Windshield Repair is readily bringing novel solutions to halt the formation of noticeable cracks from chips on the windshield with the launch of their patented Patsco Windshield Repair Patch. The Patsco Windshield Repair is a patented windshield repair product that is simple to use yet effective. It also affords drivers the opportunity to achieve their daily plans, be available for work, and be early for any appointment in spite of a chip on their windshields. Furthermore, the Patsco Patch can be kept handy in the glove department to use when needed without unsightly blemishes and ugly spots in sight on the repaired area.

With easy and simple directions, the Patsco Patch can be applied without expertise from the car owner or any equipment whatsoever, as the user is required to simply stick the Patch, push, peel, and seal it under the shade to ensure that the windshield is as good as new. The Patsco Windshield Repair Patch is ideal for vehicle owners between the ages of 21 to 75 years who want to nip the chip at the bud.

For more information, please visit https://www.patscopatch.com

About Patsco Windshield Repair

Patsco Windshield Repair was founded in1995 by Patrick McClain who is also a managing member of the company.

Media Contact
Company Name: Patsco Windshield Repair
Contact Person: Reginald McClane
Email:Send Email
Phone: (281) 804-0933
Address:5635 NW Central DR Suite E-100
City: Houston
State: TX 77092
Country: United States
Website: http://patscowindshield.com

PAYC Finance Presale July 31 2022: +385,945.8% APY Auto-Staking and Auto-Compounding Platform with 9% BUSD reflections

PAYC Finance provides a decentralized financial asset which rewards users with a sustainable fixed compound interest model through use of it's unique ASAR protocol.

The PAYC Finance Auto-Staking Protocol and Auto-Reflection (ASAR for short) is a new financial protocol that makes staking easier, more efficient and awards $PAYC Finance token holders the highest stable returns in crypto.

ASAR gives the PAYC Finance token automatic staking and compounding features include BUSD Reflection, and the highest Fixed APY in the market at 385,945.80% for the first 12 months.

PAYC Finance team is a diverse group of high-skilled developers, security experts and best viral marketers. We have analyzed every successful product in the DeFi space to bring you a break through product on the market today!

Easy and Safe Staking - The easiest auto-staking in Defi. We provide Autostaking right in your wallet, the PAYC Finance token always stays in your wallet so it doesn’t need to be put in a centralized authority. All you need to do is buy, hold and automatically receive rewards in your wallet so there’s no more complicated staking processes at all.
PAYC Finance Dividend - 9% of all trading fees are stored in the PAYC Finance Dividend Fund (PDF), which helps to achieve a variety of outcomes, including most profitable, stability and long-term sustainability.
Fastest Auto-compounding protocol - The PAYC Finance Protocol pays every PAYC Finance Token holder every 15 minutes and 96 times everyday, making it the fastest auto-compounding protocol in crypto.
Auto Token Burn - One of the most exciting features of the PAYC Finance Protocol is an automatic token burn system named “The Fire Pit” which prevents circulating supply getting out of hand and becoming unmanageable. The stone Fire burns 2.5% out of PAYC Finance Token transactions.
Highest Fixed APY - PAYC Finance pays out at 385,945.80% in the first 12 months, the highest you can get anywhere in the world. After the first 12 months the interest rate drops over a predefined Long-term Interest Cycle period.
PAYC Finance has entered into a cooperation with Pandas Yacht Club (PAYC).

5% of the total supply of the PAYC tokens will be sent to the NFT holders. All those who buy a PAYC NFT receive a share of PAYC tokens. Buy your PAYC NFT now and benefit from free PAYC tokens.

PAYC Finance will use pinksale finance to launch the token 31 july 2022:

https://www.pinksale.finance/launchpad/0x2e617d8B1574beC6F840e22A93bE78d8792D5493?chain=BSC

- NO EXTRA MINT OR HIDDEN TOKENS

- NO RUG PULL

- NO BOTS

- AUDIT

- KYC

Vision & Mission

Our mission and vision is to revolutionize the reward generation mechanism with our very first and unique protocol that has advanced profit making. PAYC Finance is equipped with innovative technologies and features that other forks lack. We aim to provide auto staking and reward multiplication protocol in the crypto space and NFT. The revolutionary PAYC Finance DeFi.

Links:

Website: https://www.payc.finance/

Whitepaper: https://payc-finance.gitbook.io/docs/

Telegram Channel: https://t.co/gzFRoAfhxa

Twitter: https://twitter.com/FinancePayc

Instagram: https://www.instagram.com/payc_finance

Youtube: https://www.youtube.com/channel/UCaQHLSCRzIH-L5aw5AWPNUQ?app=desktop

Linktr.ee: https://linktr.ee/paycfinance

Media Contact
Company Name: PAYC Finance
Contact Person: Major & Sayajin
Email:Send Email
Country: Switzerland
Website: https://www.payc.finance/

Kaylene Chute Drops Her Debut Single Skimming the Surface

Talented singer and songwriter, Kaylene Chute, announces the release of "Skimming the Surface," her debut record, as she officially introduces herself to music lovers across the globe.

Kaylene Chute has taken her pursuit of using her songwriting skills and amazing vocals to touch lives across the globe to another level as she drops her first single titled Skimming the Surface. The multifaceted entertainer will officially drop the record on Friday the 15th of July, 2022, to be available on all major streaming platforms, including Spotify.

“I am fueled not only for my passion to listen to and create music but to also feel music in my soul. I am eager to learn about the music industry and to grow professionally within the industry.” – Kaylene Chute.

The music industry has evolved over the years, with several acts emerging to deliver captivating content across genres. However, Kaylene Chute is looking to take the listening experience to a whole new level, a claim substantiated by the upcoming release of her first record, Skimming the Surface.

Kaylene Chute always had music in her DNA, beginning songwriting at a very young age. She was able to overcome the sense of insecurity and lack of confidence in her songwriting and singing skills to start sharing her art with others via Instagram. The gorgeous singer caught the attention of the producer of Skimming the Surface, who reached out to her on Instagram, and the rest they say is history.

Skimming the Surface will undoubtedly set the pace for more great works to come from the beautiful, talented Kaylene Chute as she takes her craft to more people in different parts of the world. There are also plans to drop the video to Skimming the Surface on YouTube.

For further information about Skimming the Surface and other works from Kaylene Chute, visit Instagram, TikTok, and Distrokid.

Media Contact
Company Name: The Singer's Company
Contact Person: Kaylene Chute
Email:Send Email
Country: Ireland
Website: https://www.instagram.com/kaylene_chute/?hl=en

Life After Death, a Pure Heart of Gold - Learn the Value of Your Life and Think Growth and Riches By Crisanto Walli

Are you someone who is always looking to better your life, or better yourself in general? Do youfeel a true connection to God and the universe around you, and are curious on how you cancontinue to grow that bond? Crisanto Walli, the author of Life After Death, a Pure Heart of Gold– Learn the Value of Your Life and Think Growth and Riches, saw the importance of writing abook that shared a story with life lessons and ways of living that anyone can relate to, andwanted to share what he has learned throughout his life within this fictional story.

His book focuses on the story of a man who transformed into a bird, and had the amazingopportunity to travel around the world and experience different ways of living, as well as learningabout important life principles and lessons that could help him grow to be a better person.Within the story are intertwined lessons, references, and characters from the Bible that help thereader connect and see the relation between caring and loving God, while also living your bestlife.

He wanted to write a book that helped his readers feel more at peace with the life they areliving, but also get them excited for the life they will experience once they enter heaven.Crisanto also dives into the concept of reincarnation, and what needs to happen for that to besuccessful. He believes that what you do on earth makes all the difference in what happens inyour afterlife, and within his book, he gives you insight on how you can have success in both.

His book is a must read for anyone looking to gain knowledge on God, the afterlife, andspirituality in general. Crisanto gives a new approach to learning about important life principlesand caring for your body, mind, and soul. Read Crisanto Walli’s book, Life After Death a PureHeart of Gold – Learn the Value of Your Life and Think Growth and Riches and see how it canbetter your life today. A copy of his book can be purchased on Amazon at https://www.amazon.com/dp/1772774812.

Amazon.ca link for book - https://www.amazon.ca/dp/1772774812

Amazon.com link for book - https://www.amazon.com/dp/1772774812

Media Contact
Contact Person: Crisanto Walli
Email:Send Email
Country: Canada
Website: WowMyNewLife.com

Foundation Maria Announced The Creation of London’s Largest Center For The Disabled and Children With Special Needs.

By building the largest center in London, Foundation Maria will positively touch the lives of thousands of British families.

Foundation Maria became the next trend British people talk about after its story took public notice and inspired many. Normally, people tend to talk about problems which are hard to solve while putting all the blame on those in power. However, a group of enthusiasts is about to change the entire game with the introduction of a social enterprise called Project FAITH. Everything started with a group of professionals from different business fields who came together to bring a positive change to society.

Statistics clearly state that over 350,000 children in the UK are currently living with life-altering disabilities, so many of them coming from low-income families giving them little-to-no access to the facilities, treatment, and support they need to live a full and capable life. This has resulted in a world where children with disabilities are left feeling isolated, vulnerable, and unsupported.

To support British families and their children with disabilities and special needs, Foundation Maria has announced the fundraising campaign for the UK's largest disability rehabilitation centre in London under Project FAITH. It will serve as a centre of faith and hope driven by Foundation MARIA, with the goal of transforming hundreds of families' lives. The centre will come with newly developed schemes aiming to repair broken systems causing enormous problems to the British people. The facility will provide state-of-the-art equipment and therapies, as well as a team of highly-trained specialists to help disabled children reach their fullest potential.

The center that will be developed will provide holistic support to the disabled and children with special needs. Updated practices will be used for children with different needs. Care and educational support services will be provided to these individuals under one roof. With this center, the lives of many families will be transformed for the better.

Making contributions to a cause meant to help children live a better life is already a big reward on its own. Additionally, those continuously helping Foundation MARIA will be officially announced at our events and presented with the chance to give a speech with the reasons behind their generosity. Supporters will also benefit from being recognized in newspaper articles, social media, and television. Upon completion of Project FAITH, we will publicly display the names of supporters with significant or continuous help throughout the process. Therefore, their names will be memorialized in history to be admired by those walking in and out of the building for generations to come.

The main mission of Foundation Maria is to work for the people and develop a better environment for the children as they are the future.

At the center that will be developed, disabled people and children with special needs will be treated by eminent specialists from around the world. The connections of Foundation Maria will be used for the purpose. This will be done digitally so that the children and their families can save time and money that would otherwise be spent traveling abroad.

Foundation Maria will also have training programs for UK professionals to adopt new practices and methods for upgrading their performances and implementing new and better therapies.

This center will also provide the scope for new research and connect scientists so that they can better the lives of kids with physiological or neurological issues. The program will help doctors and scientists engage in research studies and encourage them to develop strategies for preventing neurological diseases in children.

Foundation Maria has teamed up with insurance providers and financial professionals so that one can provide affordable services to families who cannot afford costly treatment for their family members. This will help in covering part or full coverage of the treatment costs.

Talking to the media Kris K (Executive Director, Foundation Maria) said “We will combine diverse environments into a single institution to give children who use our services comprehensive, all-around assistance while utilising the most cutting-edge best practices for the most potent therapies and treatments available. We appreciate all efforts made to aid us in this purpose, thus we gratefully accept both money and non-financial contributions. Every penny from donations will go towards our cause to build Project FAITH.”

For more details, visit: https://tinyurl.com/4xyrbpty.

For updates, follow:

Facebook: https://www.facebook.com/Foundation-MARIA-108392581915301/

Instagram: https://instagram.com/foundation_maria

About Foundation MARIA:

Foundation MARIA is a social programme driving the realisation of Project FAITH by engaging both individuals and organisations for philanthropic funding. Foundation MARIA is working towards the realisation of Project FAITH which is the name standing behind a rehabilitation centre for children with disabilities and special needs. Its professional team consists of personnel from different fields. Their vision is to build the largest rehabilitation centre in London which will create a better life for children with disabilities and special needs.

Watch The Video On Foundation MARIA: https://www.youtube.com/watch?v=SPukX4jcnXE

Media Contact
Company Name: Foundation Maria
Contact Person: Support
Email:Send Email
City: London
Country: United Kingdom
Website: foundation-maria.com

New York Cryogen, Inc. Recognized by AMA and Insurance Companies

Delivering High Pressure Cryotherapy with a Proprietary Mobile Device

New York, New York - June 30, 2022 - New York Cryogen, Inc. has achieved recognition from the American Medical Association (AMA). This recognition as a medical procedure is confirmed by the issuance of exclusive Current Procedural Terminology (CPT) insurance billing codes. The assignment of an exclusive CPT code means that healthcare insurances including government and private plans will now honor medically necessary high pressure cryotherapy billings.

This breakthrough recognition from the AMA and the assignment of an exclusive CPT insurance code is a major step towards New York Cryogen, Inc’s ability to offer its therapeutic services to more people. The acceptance as a recognized medical therapy will enable more patients and clients to experience the benefits of high-pressure cryotherapy with the help of health insurance coverage.

The AMA recognition and assignment of CPT will further accelerate the development and implementation of cryotherapy protocols for healing, revitalizing and repairing muscle damage, as well as delivering safe effective pain management treatments for chronic and acute conditions.

New York Cryogen, Inc. is in the final phases of rolling out its innovative mobile handheld high pressure cryotherapy device to providers throughout the nation and world. Its current extensive use of the device while performing mobile cryotherapy sessions in homes and offices is proving its durability, functionality and effectiveness.

How New York Cryogen, Inc. Works

The innovative portable therapeutic medical device is used to lower the body temperature in the targeted area to a predetermined minimum. The lower body temperature causes blood vessels and tissues to tighten and constrict. The body focuses on redirecting energy and blood flow to the core.

During the therapy session the New York Cryogen, Inc. handheld portable medical device delivers liquid CO2 or carbon dioxide to produce effective results. Upon completion of the procedure there is a gradual restitution of the body’s temperature to a normal range. This allows blood to return to normal circulatory pressure levels. This reheating of major muscle groups results in a restorative effect, providing for greater range of motion and recovery.

Observational and clinical trials of continued high pressure cryotherapy use note that muscles adapt and improve over time. The result is shortened muscle repair and recovery times. High pressure cryotherapy technology eradicates inflammation, a recognized cause of muscle, organ and health stress. In response to the opioid crisis cryotherapy has proven to be effective in pain management.

High Pressure Cryotherapy Applications

Ongoing and completed clinical trials focus on a variety of recovery, health and cosmetic benefits of the applications of high-pressure cryotherapy. As a medical procedure that aids in treatment, cryotherapy technologies focus on:

• Pain Management

• Muscle Recovery and Repair for Athletes

• Post-Surgery Recovery

Along with recognized medical uses cryotherapy applications are being assessed and utilized with continued promising results for cosmetic applications. Clients and patients seek mobile treatments with cryotherapy by New York Cryogen, Inc. for:

• Body Sculpting (Targeted fat reduction)

• Acne Treatments

• Fine skin wrinkles and jawline tightening

Aesthetic procedures that are deemed “not medically necessary” will not be covered under the average a majority of standard healthcare plans.

Gregory N. Papageorge, the CEO and founder of New York Cryogen, Inc. and a driving force in its acceptance by the medical community, recently stated, “As the first company to have exclusive CPT billing codes combined with our proprietary high-pressure cryotherapy mobile medical device, New York Cryogen, Inc. is well positioned to expand our services to a broader base of clients, patients and customers who will benefit from this innovative medical therapy.”

About New York Cryogen, Inc.

New York Cryogen, Inc. with a home office located at Siege Athletics at 228 East Jericho Turnpike, Mineola, New York 11501, is a mobile therapeutic provider of cryotherapy. In providing mobile cryotherapy services 7 days a week at the homes and offices of clients and patients, New York Cryogen, Inc. has researched and developed a proprietary mobile device. Upon final testing, the New York Cryogen, Inc. cryotherapy mobile medical device will be available for distribution nationally as well as globally.

Media Contact
Company Name: New York Cryogen, Inc.
Contact Person: Media Relations
Email:Send Email
Phone: (516) 441-9118
Country: United States
Website: https://nycryogen.com/